Anti-Ly6E Exatecan ADC M7437 in Advanced Solid Tumors
EMD Serono
EMD Serono
Seagen Inc.
Seagen Inc.
Eli Lilly and Company
Kivu Bioscience Inc.
M.D. Anderson Cancer Center
Genentech, Inc.
AstraZeneca
Bristol-Myers Squibb
Exscientia AI Limited
KaliVir Immunotherapeutics
Fate Therapeutics
IDEAYA Biosciences
Radiopharm Theranostics, Ltd
AstraZeneca
Terremoto Biosciences Inc.
Ensem Therapeutics
Mayo Clinic
Eli Lilly and Company
Neonc Technologies, Inc.
Radiopharm Theranostics, Ltd
Tizona Therapeutics, Inc
Clasp Therapeutics, Inc.
Exscientia AI Limited
Daiichi Sankyo
Normunity AccelCo, Inc.
DualityBio Inc.
MacroGenics
SystImmune Inc.
Grey Wolf Therapeutics
Innate Pharma
Dren Bio
Elephas
OncoNano Medicine, Inc.
Tanabe Pharma America, Inc.
Therorna
West China Hospital
DualityBio Inc.
Volastra Therapeutics, Inc.
LigaChem Biosciences, Inc.
Nurix Therapeutics, Inc.
Guardant Health, Inc.
Bicara Therapeutics
Yuhan Corporation
Medicenna Therapeutics, Inc.
Precision Biologics, Inc
Portage Biotech
Cancer Research UK
Evopoint Biosciences Inc.
HRYZ Biotech Co.